title: Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus.
abstract: Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus.
authors: Department of Dermatology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
authors: Ye Won
authors: YW
authors: Han
authors: Hyung Ok
authors: HO
authors: Kim
authors: Sung Hwan
authors: SH
authors: Park
authors: Young Min
authors: YM
authors: Park